Does an Al2O3 or ZnO atomic layer coating inhibit crystallization of ASD powders in general, whatever the hydroxyl groups, polymer hygroscopicity, manufacturing route, particle size and coating thickness, and by what mechanism?
Yes, as a delay: uncoated powders crystallized in about 1–2 weeks, coated ones at 3–24 weeks or, in 7 of 13 coated arms, not within 48 weeks. The surface-mobility mechanism was argued, not measured. ··
In four drug–polymer ASDs (erlotinib with HPMCAS or PVPVA, naproxen with HPMCAS, lumefantrine with PVPVA), spray-dried or extruded and stored at 40 °C and 31–75% RH, Al2O3 or ZnO atomic layer coatings of 5–25 nm "effectively delayed or completely inhibited" crystallization, and the authors take the effect as general: it held with or without hydroxyl anchoring groups and across polymer, manufacturing route, particle size and coating thickness or material. ···· Coated powders that still crystallized did so, in the authors' reading, through bulk mobility, with higher humidity lowering the wet Tg ("This confirms"); for erlotinib "the study results suggest" that polymer choice matters more than anchoring groups. ·· The inhibition "is attributed primarily to decreased surface molecular mobility": the coating did not reduce bulk water uptake, and the authors propose that it blocks surface water adsorption or directly restricts the mobile surface layer, but surface mobility, surface water adsorption and coating–surface bonding were not measured. ··· The coatings also improved the flow of lumefantrine/PVPVA powders, and the authors propose ALC as a potentially scalable route to more stable, higher-loading ASDs, although no drug-loading series was made. ····
01Why this study
Residual crystallinity can lower the supersaturation reached and so bioavailability.
Surface crystallization is orders of magnitude faster than bulk; thin polymer and other coatings delayed it.
Shi 2016, ref 29; Wu 2007, ref 34 ··
An Al2O3 atomic layer coating kept a 70% ezetimibe/HPMCAS ASD amorphous at 40 °C/75% RH for about 2 years.
Van Duong 2022, ref 25
On hydroxyl-bearing surfaces ALC forms a sharp layer; without them the precursor diffuses into the subsurface.
Jur 2010, ref 54 ·
More detail
What was already known. The introduction builds on these points:
- Crystallinity undermines amorphous formulations. Amorphous drugs dissolve faster than crystals but have a driving force to crystallize; a polymer mixed into an ASD inhibits this for many systems, within thermodynamic and kinetic limits set largely by drug loading (DL). Trace crystallinity can reduce attainable supersaturation and bioavailability. (Jermain 2018, ref 1; Williams 2013, ref 2; Newman 2022, ref 3; Lin 2018, ref 5; refs 6–10)
- Mobility and water govern stability. A classic rule says an ASD is kinetically stable when stored at least 50 °C below its Tg, although stability of 15–25 years has been reported for samples stored only 10 °C below Tg. (Hancock 2001, ref 13; Theil 2017, refs 14, 15) Water is absorbed into the bulk of amorphous solids, plasticizes them even at low levels, and can disrupt hydrogen bonding or miscibility, leading to phase separation and crystallization. (Mehta 2016, ref 16; Rumondor 2009, ref 17) The manufacturing process also changes crystallization rates. (refs 18–21)
- Surface crystallization is the weak point. Surface crystallization is orders of magnitude faster than bulk crystallization, so limiting mobility at the surface could inhibit crystallization well. Thin films of PVP, dextran, alginate, gold, polyelectrolyte, gelatin and chitosan have delayed crystallization on films and particles; Yu and co-workers linked surface crystallization to a more mobile surface layer that a coating can arrest. (Shi 2016, ref 29; refs 30–36) ··
- Conventional coatings are thick and solvent-based. Those coatings rely on non-covalent adhesion and need relatively thick layers, on the order of tens to hundreds of microns, usually sprayed from solvent. Solvent coating is unsuited to single particles, and dry coating methods need high temperature or long curing. (refs 37–46)
- ALC is thin, conformal and solvent-free. ALC builds a metal-oxide film, commonly under 10–100 nm, one atomic layer per cycle, with fine control of thickness and conformality; it is used on semiconductors, solar cells and medical devices, and has improved the flow of organic drug powders. (George 2010, ref 47; Adhikari 2018, ref 48; Parsons 2013, ref 49; refs 25, 50–53)
- ALC stabilized one high-loading ASD. In the group's earlier study, Al2O3 ALC inhibited crystallization of a 70% ezetimibe/HPMCAS spray-dried ASD at 40 °C/75% RH for about 2 years; thinner (<20 nm) and thicker (>30 nm) coatings differed in onset, and water sorption fell with coating thickness. (Van Duong 2022, ref 25)
- Surface chemistry decides how the film grows. On substrates with hydroxyl groups ALC gives an abrupt, well-defined interface and controlled thickness; on substrates without reactive groups the precursor and water diffuse into the subsurface, causing swelling, subsurface particle growth and a rough texture. The authors infer that hydroxyls on drug or polymer may act as anchoring sites and that coating quality may affect how well the film prevents water sorption or reduces surface mobility. (Jur 2010, ref 54; Parsons 2013, ref 49) ·
What the paper set out to do. Test whether crystallization inhibition by ALC is general, using several drug–polymer systems chosen for a range of hygroscopicity and functional groups and made by spray drying or hot melt extrusion. Use two coating materials, Al2O3 and ZnO, chosen as biocompatible inert materials already used in cosmetics, food and medicines, at several thicknesses, aiming to find a minimum effective thickness. Follow crystallization by SEM and XRPD, and characterize the powders by DSC and water sorption. ·
02How they approached it
Four drug–polymer systems in a 2 × 2 grid by whether drug and polymer carry hydroxyl groups (possible anchoring sites); each coated powder was stored beside its uncoated powder at 40 °C. LUM/PVPVA was also made by two routes and sizes. ·····
What was done
Four drug–polymer systems in a 2 × 2 grid of hydroxyl groups→spray drying, or hot melt extrusion with cryomilling and sieving (LP40 by both routes, two sieve fractions).···
Al2O3 or ZnO coating in a rotary ALC reactor at 35 °C→thickness from TGA oxide content and BET surface area, checked by cross-sectional TEM.···
Size, flow, dry Tg, recrystallization on heating and water sorption, with and without coating.···
Open storage at 40 °C and 31, 43 or 75% RH for up to 48 weeks, coated beside uncoated→crystals by SEM and XRPD.··
Wet Tg after 24 h at each storage humidity→Tg − T.·
Onset of each coated arm against its uncoated powder, across systems, thickness, material, route and humidity, and against Tg − T (Figs. 9, 10).·
More detail
What was done
- ASD preparation. EH60, EP50 and LP40-SD were spray dried (Buchi 290, nitrogen, 10% solids; methanol/dichloromethane for the erlotinib systems, ethyl acetate/dichloromethane for LP40; inlet 90–105 °C, outlet 60–68 °C). NH10 and LP40 were extruded (Haake MiniCTW, 160 and 150 °C, 200 rpm), cryomilled 3 min at 10 Hz under liquid nitrogen and sieved to 0–250 µm (NH10) or 0–106 and 106–250 µm (LP40). Table 2 prints "LP40-HME-B" for both LP40 fractions; elsewhere the 0–106 µm fraction is HME-A. ···
- Atomic layer coating. A rotary reactor agitated the powder at 35 °C under vacuum (0.1 Torr). Each cycle dosed trimethylaluminum (Al2O3) or diethylzinc (ZnO), purged with nitrogen, dosed water as co-reactant, and purged again; cycles were repeated to the target thickness, with precursor amounts set from the BET surface area. The number of cycles is not printed.
- Coating thickness. TGA burned off the organic matter to 800 °C; the residue was taken as oxide content (0.50–5.60%) and converted to a thickness with the BET surface area (7.4–24 nm). These TGA values name the samples. Cross-sectional TEM after FIB lift-out measured six coatings (4.4–37.7 nm). ····
- Powder and solid-state tests. Particle size by laser diffraction (n = 3); flow function and compressibility at 15 kPa by FT4 shear cell, LP40 only, with paired one-tailed t-tests; dry Tg and recrystallization on heating by DSC at 5 °C/min in open pans; water sorption–desorption at 40 °C from 0 to 95% RH by DVS. ···
- Stability. Powders were stored in open dishes in sealed containers at 40 °C over saturated salt solutions at 31, 43 or 75% RH and examined periodically by SEM (the primary detector, judged more sensitive than XRPD or DSC) and XRPD, for up to 48 weeks (NH10 XRPD to 24 weeks). Selected crystallized particles were cut and imaged by TEM. Sample numbers per arm and SEM sampling times are not printed. ····
- Mobility at storage. After 24 h at the storage condition, wet Tg was measured in hermetic pans (triplicate) and Tg − T computed with T = 40 °C. ·
Key equations
The wet Tg, measured after 24 h at the storage humidity, minus the storage temperature of 40 °C; a negative value means the powder was stored above its Tg. The paper sets it against crystallization onset to argue that coated powders which still failed did so through bulk mobility.··
An ASD is taken to be kinetically stable when stored at least 50 °C below its Tg. The authors use it as the benchmark: coated powders held at Tg − T of only about 0–15 °C.··
Terms used on this page
- Atomic layer coating (ALC): a solvent-free gas-phase process that grows an oxide film one layer per cycle through two surface reactions, a metal precursor and then water. Also called atomic layer deposition.
- Conformal coating: a film of the same thickness on every surface, flat or curved.
- Anchoring sites: surface groups, here hydroxyls, that the precursor reacts with. Without them the precursor may infiltrate the subsurface instead of forming a sharp layer.
- TGA thickness: coating thickness estimated from the oxide left after burning off the organic matter and from the specific surface area; used as the sample label.
- Wet Tg: the Tg of a powder after 24 h at its storage humidity. Tg − T: wet Tg minus the storage temperature (40 °C); a negative value means the powder was stored above its Tg.
- Onset: the first storage time at which SEM showed crystals.
- Flow function (FF): a shear-cell measure of how easily a consolidated powder flows; below 2 very cohesive, 2–4 cohesive, 4–10 easy flowing, above 10 free flowing. Compressibility: percent volume loss under 15 kPa.
- Absorption and adsorption: water taken into the bulk versus water held on the surface.
03Main findings
Uncoated powders crystallized within 1–2 weeks; every coating delayed it
All eight uncoated system/humidity sets crystallized by SEM in about 1–2 weeks at 40 °C. Coated arms crystallized at 3–24 weeks, or not within 48 weeks in 7 of 13 arms.
See also Fig. S10
More detail
Onset by SEM, uncoated → coated, at 40 °C (Figs. 9 and 10) :
- EH60 at 75% RH: about 2 weeks → about 3 weeks with 13 or 14 nm Al2O3.
- EH60 at 43% RH: about 2 weeks → no crystals at 48 weeks with 13 nm Al2O3.
- EP50 at 43% RH: about 2 weeks → about 6 weeks with 7.4 or 14 nm Al2O3.
- NH10 at 75% RH: about 1–2 weeks → about 24 weeks with 9.8 nm Al2O3. ·
- LP40-SD at 43% RH: about 1–2 weeks → about 24 weeks with 8 nm Al2O3.
- LP40-SD at 31% RH: about 2 weeks → no crystals at 48 weeks with 8 or 11 nm Al2O3 or 8.7 nm ZnO.
- LP40-HME-A at 31% RH: about 1 week → no crystals at 48 weeks with 11 or 19 nm Al2O3.
- LP40-HME-B at 31% RH: about 1 week → no crystals at 48 weeks with 24 nm Al2O3.
The uncoated NH10 and LP40-SD (43% RH) onsets are about 1 week in the Fig. 9 bars and 2 weeks in the Fig. 10 table; the results text gives "1−4 weeks" for uncoated powders, the abstract and both figures 1–2 weeks. · In SEM, uncoated EH60 and EP50 particles fused into agglomerates carrying faceted plates, uncoated NH10 and LP40-HME surfaces carried needles or rods, and uncoated LP40-SD spheres carried small protrusions, while coated particles stayed discrete without needles or plates (extractor reading of Fig. 8). Stored coated EH60 and EP50 powders stayed fine and loose while uncoated ones clumped (Fig. S10). The authors write that crystallization was "effectively delayed or completely inhibited", and that ALC enabled stability at a higher drug loading or harsher storage than possible without it; no drug-loading series was made. ··
Hydroxyl anchoring groups were not needed, but the polymer mattered
EP50, with no hydroxyl groups, still went from 2 to 6 weeks at 43% RH. At similar Tg − T (−0.5 vs −2.3 °C), coated EP50 crystallized at 6 weeks while coated EH60 stayed amorphous for 48 weeks. ·
More detail
Every hydroxyl class gained from the coating: none (EP50, 2 → 6 weeks at 43% RH), polymer only (EH60, 2 → 3 weeks at 75% RH and 2 → more than 48 weeks at 43% RH), drug and polymer (NH10, 1–2 → 24 weeks at 75% RH) and drug only (LP40, all coated powders stable at 31% RH). ·· The authors note that ALC has also been deposited on substrates with other groups such as amines (ref 66).
The coatings looked different by TEM (Fig. 4). On EH60 the Al2O3 layer (marked 20.3 nm) had a sharp boundary with the particle; on EP50 a layer marked 9.4 nm sat over a lighter band labelled "infiltration"; the ZnO layer on LP40-SD (marked 8.6 and 9.6 nm) had uneven, mottled contrast. The authors call most coatings conformal, say infiltration on EP50 "is suggested by the TEM imaging", and match it to subsurface growth seen on polymers without anchoring sites (refs 49, 54). ZnO "appears to be less conformal", which they relate to its microcrystalline character and read as "reduced bonding"; it still protected LP40-SD as well as Al2O3. ····
The erlotinib pair is the authors' evidence that polymer choice matters more than hydroxyl groups: at 40 °C/43% RH both had Tg − T near zero (EH60 −2.3 ± 1.1 °C, EP50 −0.5 ± 1.2 °C), yet coated EP50 crystallized at 6 weeks and coated EH60 not within 48 weeks. They add that HPMCAS carried a higher erlotinib loading (60 vs 50%) and cite Mudie (ref 27) for enteric polymers suiting erlotinib; "the study results suggest" that HPMCAS suits amorphous erlotinib better, and acid–base interactions "are likely" the reason (ref 24). ···· Each loading was made only once, so the loading argument is not a measured limit.
Humidity, not coating thickness, material or particle size, decided whether coated powder held
Thickness pairs gave the same onset (EH60 13 vs 14 nm: 3 weeks; EP50 7.4 vs 14 nm: 6 weeks); ZnO, SD and HME powders all held at 31% RH. Coated EH60 held at 43% RH but failed at 3 weeks at 75% RH. ·
See also Fig. 9
More detail
- Thickness. EH60 with 13 and 14 nm both crystallized at about 3 weeks at 75% RH; EP50 with 7.4 and 14 nm both at about 6 weeks; LP40-SD with 8 and 11 nm and LP40-HME-A with 11 and 19 nm all held for 48 weeks at 31% RH. The authors conclude that "No minimum coating thickness was required": 7–8 nm sufficed, with "limited differentiation" from coatings above 15 nm. ·· The thicker EP50 coating is 14 nm in Table 3 and 14.5 nm in the figures.
- Material. On LP40-SD at 31% RH, 8.7 nm ZnO and 8 or 11 nm Al2O3 all held for 48 weeks. ·
- Route and particle size. LP40 made by SD (D50 13.6 µm) and by HME (D50 28.5 and 151 µm) crystallized in 1–2 weeks uncoated and held for 48 weeks coated at 31% RH. The authors see "limited differentiation" with particle size or route. ··
- Humidity. The same coated EH60 (13 nm) held for 48 weeks at 43% RH but crystallized at about 3 weeks at 75% RH; coated LP40-SD (8 nm) held at 31% RH but crystallized at about 24 weeks at 43% RH. The authors attribute this to moisture raising mobility and lowering the wet Tg (refs 67, 68). · Uncoated onsets did not shorten with humidity (EH60 2 and 2 weeks; LP40-SD about 2 and about 1 week).
Wet Tg − T only partly orders the coated failures
Tg − T ran from about −8.8 to +14.3 °C. Coated erlotinib powders stored above their wet Tg failed within 6 weeks, except EH60 at 43% RH (−2.3 °C), which held; coated NH10 and LP40-SD at 43% RH (about +11 °C) failed at 24 weeks. ··
More detail
Tg − T at each storage condition (Fig. 10), with onset uncoated → coated ·:
- EH60 at 75% RH: about −8.8 °C; 2 → 3 weeks.
- EH60 at 43% RH: −2.3 ± 1.1 °C; 2 weeks → stable.
- EP50 at 43% RH: −0.5 ± 1.2 °C; 2 → 6 weeks.
- NH10 at 75% RH: about +11.3 °C; 2 → 24 weeks.
- LP40-SD at 43% RH: about +10.7 °C; 2 → 24 weeks.
- LP40-SD, LP40-HME-A and LP40-HME-B at 31% RH: about +14.3, +11.3 and +11.4 °C; 1–2 weeks → stable.
The authors write that onset "can be linked" to these values: the least stable arms had negative Tg − T and the longer-lived ones "generally" positive values, and "This confirms that the mobility of the sample was the primary mechanism" for the coated failures, rather than chemistry or particle attributes. · The text places EP50 at 75% RH, but it was stored only at 43% RH. Across the uncoated arms, onset was about 1–2 weeks whatever the Tg − T, and the stable EH60 arm at −2.3 °C sits outside the "approximately 0−15 °C" range the discussion gives; whether wet Tg was measured on coated or uncoated powder is not stated, and the wet Tg values themselves are not printed. ·
The coating did not reduce water uptake, and Al2O3 left Tg unchanged
Sorption isotherms with and without coating overlapped up to 75% RH. Al2O3 changed dry Tg by at most 2.6 °C, but ZnO lowered LP40-SD from 65.5 to 57.3 °C. ···
More detail
At 75% RH, EH60 took up about 5.7% water uncoated and 5.4% coated; EP50 took up about 14.6 vs 15.9% at 85% RH and 26.7 vs 28.2% at 95% RH. For NH10 and the LP40 powders the sorption curves agreed within about 1% up to 75% RH; at 95% RH coated and uncoated values were about 9.8 vs 8.9% (NH10), 31.6 vs 33.2% (Al2O3) and 29.7% (ZnO) for LP40-SD, and 26.2–26.9% uncoated vs 26.7–31.6% coated for the HME fractions. The authors conclude that 5–25 nm coatings leave sorption unchanged and that the LP40 profile did not depend on route or size. Because Al2O3 films are known to block water better as they thicken and fewer defects remain (ref 69), and thicker ALC reduced sorption in ezetimibe/HPMCAS and in lactose (refs 25, 70), they read the result as "indicating that the water permeation rate was not sufficiently reduced" by these thin coatings. ·
Dry Tg (Table S1) moved by −1.8 to +2.6 °C with Al2O3, for example EH60 44.6 → 43.9 and 44.0 °C, NH10 78.1 → 80.7 °C; ZnO on LP40-SD gave 57.3 against 65.5 °C. The authors state that the coating "does not alter" Tg, which holds for Al2O3 only. ··
Coated powders flowed better and clumped less
For LUM/PVPVA, flow function rose from about 1.4–2.4 uncoated to about 3.1–11.9 coated, and compressibility fell. Stored coated powders stayed loose while uncoated powders clumped. ·
More detail
Flow function and compressibility at 15 kPa, uncoated → coated (Fig. 5) :
- LP40-SD: FF about 1.4 → 3.1 (8 nm Al2O3, p < 0.05) and 4.2 (8.7 nm ZnO, p < 0.01); compressibility about 44.6 → 26.2 and 35.3% (both p < 0.05).
- LP40-HME-A: FF about 1.9 → 11.9 (19 nm Al2O3, p < 0.01); compressibility about 26.5 → 16.7% (p < 0.05).
- LP40-HME-B: FF about 2.4 → 7.7 (24 nm Al2O3, p < 0.05); compressibility about 27.8 → 22.6% (not significant).
The authors describe FF as "consistently improved by the application of ALC, regardless of particle size" and compressibility as improved more for smaller particles, in line with earlier ALC work on organic powders (refs 25, 52, 62). ·· Only LP40 was tested, the replicate number is not printed, and coated LP40-HME-A had a smaller main particle mode than its uncoated powder (about 27 and 16 µm vs 40 µm), although the authors state ALC did not alter particle size. ···
04Further observations
- TEM and TGA thickness differ up to about two-fold (EH60: 13 nm by TGA, 20–21 nm by TEM). ·
- On DSC heating, coated EH60 and EP50 showed smaller, broader recrystallization exotherms than uncoated.
- XRPD saw crystals later than SEM, and in uncoated LP40-HME not within 48 weeks. ·
- On a crystallized coated EH60 particle, crystals sat on top of a continuous ALC layer 7–9 nm thick.
- In DVS, uncoated EH60 lost mass between 85 and 95% RH; coated EH60 did not. ·
More detail
- Coating thickness by two methods. TGA gave 7.4–24 nm and TEM 4.4–37.7 nm; the TEM/TGA ratio ran from about 0.6–0.7 (EP50, 7.4 nm by TGA, 4.4–5.5 nm by TEM) to about 1.5–2.0 (EH60 13 nm: 20–21 nm; LP40-HME-A 19 nm: 29.8–37.7 nm). The authors call them "generally consistent". Two LP40-SD coatings labelled 8.0 and 11 nm share the same oxide content (3.47%). ···
- Recrystallization on heating. Uncoated EH60 showed a sharp exotherm peaking near 105 °C and a melting endotherm near 150 °C; coated EH60 gave a small broad exotherm between about 105 and 125 °C. Uncoated EP50 showed an exotherm near 122 °C and endotherm near 139 °C; coated EP50 only weak exotherms near 130 °C (temperatures read from Fig. 6). NH10 and LP40 were not reported to recrystallize on heating. The authors say crystallization was delayed and its enthalpy reduced, more so with thicker coatings; no enthalpies are printed and the 13 and 14 nm EH60 traces look alike. ···
- XRPD versus SEM. Uncoated EH60 at 75% RH showed sharp peaks from 2 weeks; coated EH60 at 75% RH none at 2 weeks, weak at 4 and clear from 8 weeks. Uncoated EP50 showed weak peaks from about 8 weeks, coated EP50 none to 24 weeks; uncoated EH60 at 43% RH faint features at 12 and peaks from 24 weeks; uncoated NH10 a peak from 8 weeks, coated NH10 a faint feature at 24 weeks only; uncoated LP40-SD at 43% RH peaks from 24 weeks. Uncoated LP40-HME-A and -B showed no peaks through 48 weeks and uncoated LP40-SD at 31% RH a faint feature at 48 weeks only, against SEM onsets of 1–2 weeks. The authors say only that XRPD detected crystals "at a slightly longer time point". ··
- ZnO in XRPD. ZnO-coated LP40-SD showed features near 31.8° and 34.4° 2θ from the fresh sample through 48 weeks and no other peaks.
- How a coated particle fails. On coated EH60 after 12 weeks at 40 °C/75% RH, SEM showed crystals on the surface and TEM showed crystals lying above a continuous ALC layer marked 8–9 nm and 7–8 nm. The authors read this as crystals growing out of the particle, as is common for amorphous materials (ref 64), with larger ones breaking off and lying flat on the coating. A coating was seen even beneath an outgrowth, which they attribute to the failure site being too small to hit by FIB cutting. The coating next to crystals (7–9 nm) was thinner than "∼14 nm" from initial TEM; they cannot tell whether this reflects particle-to-particle variation or storage. Which EH60 coating was imaged is not stated, and Table 3 gives 20–21 nm by TEM for the 13 nm sample. ····
- Sorption at high humidity. Uncoated EH60 reached about 7.6% at 85% RH and then fell to 6.8% at 95% RH, with desorption below sorption; coated EH60 reached about 9.8% at 95% RH. The authors read the drop as crystallization during DVS, which the coating prevented; no solid-state check after DVS is shown. ··
- Dry Tg puzzles. Dry Tg of EH60 and EP50 (43.9–44.6 °C) lies below the Tg of every component (erlotinib 54, HPMCAS 114, PVPVA 103 °C), and spray-dried and extruded LP40 of the same composition differ by about 12–13 °C; water content before DSC is not reported. ····
- Particle size. The size distributions of NH10, LP40-HME-B and EH60 were almost unchanged by coating; LP40-SD and EP50 are bimodal with changed mode heights, and LP40-HME-A shifted (see F6). ·
05How the authors connect the findings
More detail
- Crystallization happens because the amorphous drug can lower its free energy, but mobility plays the key kinetic role. Surface crystallization is orders of magnitude faster than bulk, so a surface treatment can act where crystals start. The authors state that the coating "successfully reduced" mobility, as other coatings have (refs 30–34). ··
- The oxide film removes the particle's free surface: the surface–air interface becomes an ASD–metal oxide interface. Two ways in which this lowers mobility are proposed.
Water route. Crystal nucleation and growth speed up with humidity because sorbed water raises mobility (refs 67, 68), shown here by shorter onsets of coated EH60 and LP40 at higher humidity. Water enters amorphous solids by absorption into the bulk and adsorption onto the surface. Bulk uptake was the same with and without coating → the coating "would block water adsorption to the particle surface" → an uncoated particle has a more mobile surface even at the same total water → it crystallizes faster. The adsorption difference "would be too small to detect". A true diffusion barrier "may act" in some systems, but 5–25 nm coatings did not reduce sorption, so the water permeation rate was not reduced enough here. ···
Surface-mobility route. The coating "may directly inhibit mobility at the surface". Yu and co-workers linked surface crystallization to a mobile surface layer that a coating can arrest (refs 33–36). In most systems the oxide could bond to the drug or polymer surface layer, which "will likely reduce mobility"; on hydroxyl-free EP50 it infiltrated the surface instead. In both cases, "where direct covalent bonding may or may not have been possible", onset was delayed. ··
- When coated particles still failed, crystals grew out of the particle and lay above the coating (Fig. 11), and the failures followed bulk mobility: arms stored above their wet Tg failed soonest. The authors write "This confirms that the mobility of the sample was the primary mechanism", rather than chemistry or particle attributes. ··
What sets the failure point. Higher storage humidity lowers the wet Tg and shortens onset. Comparing with the earlier ezetimibe study, where coatings under 20 and over 30 nm differed, the authors suggest that failure "may be based on coating thickness, potentially due to coating conformality", that is fewer defects in thicker films; all coatings here fall in the thinner group, which they say explains why thickness made no difference. ·· Polymer choice also mattered for erlotinib (F2).
Conclusion drawn. Abstract: the effect "is attributed primarily to decreased surface molecular mobility". Discussion: under either mechanism ALC "shows clear benefit for systems at high risk to crystallize", stabilizing ASDs at Tg − T of about 0–15 °C, far below the 50 °C rule of thumb (ref 13). ··
06What it means for formulation
- ALC "has the potential to be a scalable strategy" to allow higher drug loading and robustness to temperature or humidity excursions.
- Better flow and less agglomeration help downstream processing, especially below about 30 µm.
- A coating protects the surface but cannot rescue a powder stored above its wet Tg; humidity control and polymer choice still come first.
More detail
- ALC "has the potential to be a scalable strategy" to enhance ASD physical stability, enabling high drug loading and robustness to temperature or humidity excursions; the conclusions say it "served to enable" stability at a higher loading or harsher storage. ·
- ALC "shows clear benefit for systems at high risk to crystallize", stabilizing ASDs at Tg − T of about 0–15 °C, well below the >50 °C rule of thumb.
- Reduced agglomeration and better flow matter for downstream processing, particularly for particles below about 30 µm, which are cohesive and compressible; other groups also saw better wettability and lower hygroscopicity.
- Polymer selection still matters: HPMCAS suited erlotinib better than PVPVA ("the study results suggest").
- Caution: spray-dried particles may be hollow, with inner surfaces the coating cannot reach, which may make them more prone to crystallize than extruded particles.
- ALC "may offer a new approach" to the poor wettability of hydrophobic drugs; release from coated ASDs needs study.
- The coating acts on the surface, not the bulk. Where the bulk is mobile (EH60 at 75% RH, stored about 9 °C above its wet Tg) it bought one week; where the bulk was near or below Tg it bought months. ALC adds to, but does not replace, a sound polymer, loading and moisture-control choice.
- At 5–25 nm the film is not a moisture barrier, so it does not replace protective packaging or desiccants.
- The process runs at 35 °C without solvent, which suits low-Tg ASDs, but nothing here tells whether the oxide shell slows dissolution or changes supersaturation; that has to be checked before use.
- The flow gain on cohesive spray-dried and milled powders may be worth having even where the stability gain is small.
07Open questions
- How does an ALC shell change wetting and drug release of ASD particles?
- Surface mobility and surface water adsorption, the proposed causes, were never measured. ·
- Each hydroxyl class is one system, and drug, polymer, loading, route, size and humidity change together.
More detail
- What are the release mechanisms of ALC-coated ASD particles, given that coatings have both sped and slowed release in other work?
- Does coating failure depend on thickness through conformality and defect density, as the earlier <20 vs >30 nm comparison suggests?
- Are hollow spray-dried particles, with uncoated inner surfaces, more prone to crystallize?
- Is the thinner coating next to crystals (7–9 nm) a result of storage and crystallization, or just particle-to-particle variation?
- Surface mobility, surface water adsorption and coating–substrate bonding were not measured; the mechanism rests on argument and cited work. ··
- One system per hydroxyl class; ZnO tested only on LP40-SD at 31% RH, where Al2O3 also held; NH10 stored only at 75% RH.
- No replicates or uncertainty on onset times; SEM sampling times not printed.
- Thickness was never compared above about 15 nm under conditions where coated powders failed.
- No drug-loading series, so the claim that ALC allows higher loading is untested.
- Dissolution, wetting and chemical stability of coated powders were not measured.
08How solid
AI assessment, not a statement made in the paperThe delay is seen in all eight system/humidity sets, against a matched uncoated powder, and SEM, photographs and DSC agree. But onset times have no replicates, XRPD does not confirm several arms, and the mechanism and generality claims rest on argument and one system per category. ······
More detail
- Every coated arm crystallized later than its uncoated powder, stored side by side at the same condition. ··
- SEM images and powder photographs show the same difference. ·
- DSC on heating shows weaker recrystallization of coated EH60 and EP50.
- Water sorption was measured directly and rules out a bulk moisture barrier at these thicknesses. ·
- Flow gains carry significance tests.
- Onset times carry no replicates or uncertainty, and the SEM sampling interval is not printed.
- XRPD shows no crystals through 48 weeks in uncoated LP40-HME, where SEM saw them at 1 week, and none or faint peaks in several coated arms that SEM scored as failed.
- The generality claim rests on one system per category, with drug, polymer, loading, route, size and humidity varied together.
- Thickness independence was not tested above about 15 nm where coated samples failed; TEM puts two coatings above 20 nm, outside the "thinner category" the authors assign. ·
- Wet Tg − T only partly orders the failures; the humidity effect appears only in coated arms; "all systems were successfully prevented" overstates arms that failed at 3–24 weeks. ··
- ZnO lowered Tg despite the claim that Tg was not altered; drug-loading statements lack a loading series. ·
- Several labels and values conflict between tables and figures (HME-B printed twice in Table 2; NH10 coating 8 vs 9.8 nm; uncoated onsets 1 vs 2 weeks). ··
- The study was co-designed and funded by Applied Materials, which employs four of the authors (competing-interest statement and acknowledgments, p. 40708).
09Figure guide
Every figure and table of the paper, what it is there for, and what to check on the original. Key figures are shown with the story.
| Figure | What it does in the paper | Supports | Check (AI note) |
|---|---|---|---|
| Fig. 1 (p.40700) | Shows the three drugs and two polymers, with the hydroxyl groups that define the design. | 0.2 | |
| Table 1 (p.40700) | Melting points and Tg of the drugs and polymers, the reference for the ASD Tg values. | 0.2 | Dry Tg of EH60 and EP50 lies below that of every component. |
| Fig. 2 (p.40700) | Schematic of one ALC cycle: precursor dose, purge, water, purge. | 0.2 | A schematic, not data. |
| Table 2 (p.40701) | Defines the six powders: process, sieve fraction, D50, surface area and hydroxyl class. | 0.2 | "LP40-HME-B" is printed for both LP40 fractions. |
| Fig. 3 (p.40701)key figure | The design: four systems placed by drug and polymer hydroxyl groups, with process, coatings and hygroscopicity. | 0.2 | A schematic, not data. |
| Table 3 (p.40702) | Coating thickness by TGA (7.4–24 nm, the sample labels) and by TEM (4.4–37.7 nm). | F3, K3, 0.4 | TEM and TGA differ up to two-fold; two LP40-SD coatings share one oxide content.· |
| Fig. 4 (p.40702)key figure | TEM of the coatings: sharp Al2O3 layer on EH60, layer plus infiltration on hydroxyl-free EP50, mottled ZnO on LP40-SD. | F2, K8 | |
| Fig. 5 (p.40703)key figure | Coating raises flow function and lowers compressibility of the three LP40 powders. | F6, K7 | Replicate number not printed; coated HME-A is finer than uncoated.· |
| Fig. 6 (p.40703)key figure | DSC on heating: coated EH60 and EP50 recrystallize less and later than uncoated. | 0.4, K1 | No enthalpies printed; the 13 and 14 nm traces look alike. |
| Fig. 7 (p.40704)key figure | Water sorption of EH60 and EP50 is unchanged by the coating; uncoated EH60 loses mass above 85% RH. | F5, K5 | Crystallization during DVS is inferred from the curve only. |
| Fig. 8 (p.40704)key figure | SEM during storage: uncoated particles fused or covered with needles and plates, coated particles smooth. | F1, K1 | |
| Fig. 9 (p.40705)key figure | The main result: SEM onset for every arm, uncoated at 1–2 weeks, coated at 3–24 weeks or none by 48. | F1, F3, K1, K2, K3, K6 | NH10 coating labelled 8 nm, not 9.8; uncoated onsets differ from Fig. 10; no replicates.·· |
| Fig. 10 (p.40705)key figure | Wet Tg − T at each storage condition beside the onset table, the basis of the bulk-mobility reading.· | F4, K4 | Tg − T only partly orders the coated failures; the definition is worded with the opposite sign.· |
| Fig. 11 (p.40706)key figure | A coated EH60 particle that failed: crystals grown out and lying above a continuous 7–9 nm coating. | 0.4, K5 | Which EH60 coating was imaged is not stated; the "∼14 nm" comparison does not match Table 3. |
More detail
| Figure | What it does in the paper | Supports | Check (AI note) |
|---|---|---|---|
| Fig. S1 (SI p.2) | Particle size distributions with and without coating, said to be unchanged. | F6, 0.4 | LP40-HME-A shifts to smaller sizes; legend swaps the LP40-SD coatings.· |
| Table S1 (SI p.3) | Dry Tg of every powder: Al2O3 changes it by at most 2.6 °C, ZnO lowers LP40-SD from 65.5 to 57.3 °C. | F5 | The "Tg not altered" claim holds for Al2O3 only.· |
| Fig. S2 (SI p.4) | Water sorption of NH10 and the LP40 powders, overlapping up to 75% RH. | F5, K5 | Branch and size-fraction labels conflict with Table 2.· |
| Figs. S3–S6 (SI p.5–7) | XRPD of EP50, EH60 and NH10 during storage: coated arms show peaks later or not at all. | 0.4, 0.8 | Captions say 48 weeks, plots end at 24; several SEM failures show no peaks.· |
| Figs. S7–S9 (SI p.8–10)key figure | XRPD of the LP40 powders: no peaks in most arms, including uncoated HME through 48 weeks. | 0.4, 0.8, K1 | XRPD misses SEM onsets of 1–2 weeks. |
| Fig. S10 (SI p.10)key figure | Photos of stored powders: coated loose, uncoated clumped. | F6, F1 | |
| Tables S2–S3 (SI p.11) | Spray-drying and extrusion conditions.· | 0.2 |